Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram
Authors: Lingzhi Li, Binghong Zhang, Bing He, Zuojiong Gong, Xiaobei Chen
Journal: Journal of Infection (2020)

We read Yang's paper with great interest. It illustrated clinical characteristics and imaging manifestations of 149 hospitalized patients with coronavirus disease 2019 (COVID-19) in Wenzhou. It showed most patients presented with a mild infection and some patients even presented with a normal chest finding despite testing positive for COVID-19.1Yang W. Cao Q. Qin L. Wang X. Cheng Z. Pan A. Dai J. Sun Q. Zhao F. Qu J. Yan F. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China.J Infect. 2020 Feb 26; (pii: S0163-4453(20)30099-2)Abstract Full Text Full Text PDF Scopus (671) Google Scholar However, the cases in Wuhan were more severe compared to Wenzhou. Fatalities associated with COVID-19 were of great public health concern. Most of all, the relationship between possible risk factors during the early period and outcome in critical cases with COVID-19 are not fully interpreted. In our study, 82 patients with critical type were selected randomly from 204 confirmed COVID-19 cases (50 death cases, 32 recovery cases and rest cases were not match or still hospitalized) occurring in Renmin hospital of Wuhan University, during Feb 1, 2020 and Feb 24, 2020. In univariate analysis, the following factors had significant differences between death group and recovery group: increased white blood cell count(p = 0.001), increased initial neutrophil count(p < 0.001), initial lymphocyte count less than 0.6 × 109/L(P = 0.007), C-reactive protein more than 100 mg/L(p<0.001), d-dimer more than 20 mg/L (p = 0.037), increased hypersensitive troponin I (p = 0.003), increased blood urea nitrogen(p = 0.003), and increased lactate dehydrogenase (p<0.001). However, multivariate analysis confirmed in early stage of disease, only four independent predictors: age>70 years (HR 1.71, 95% CI 0.94–3.12), initial neutrophil count (HR 2.04, 95% CI 1.08–3.85), blood urea nitrogen (HR 1.87, 95% CI 1.03–3.41) and LDH (HR 4.16, 95% CI 1.85–9.33) were related to outcome of COVID-19. The survival rate of critical COVID-19 at early stage of disease could be calculated by nomograph which derived based on the multivariate Cox regression coefficients (Fig 1). Comorbidities are associated with old age generally. Chen suggest that 2019­nCoV is more likely to infect older adult males with chronic comorbidities as a result of the weaker immune functions of these patients.2Xu X. Chen P. Wang J. Feng J. Zhou H. Li X. et al.Evolution of the novel coronavirus from the ongoing wuhan outbreak and modeling of its spike protein for risk of human transmission.Sci China Life Sci. Mar 2020; 63 (Epub 2020 Jan 21): 457-460https://doi.org/10.1007/s11427-020-1637-5Crossref PubMed Scopus (1620) Google Scholar Although chronic diseases such as hypertension, diabetes mellitus, renal diseases, heart diseases, COPD, mental diseases and malignant tumors were not different between died and recovered groups with critical COVID-19. However, as one of independent risk factors, old age (>70years) related chronic comorbidities still plays an important role in outcome of critical cases. One of the independent risk factors related to morbidity of COVID-19 was neutrophil count. The increased neutrophil count may indicate progression of disease initially.3Xun Li, Luwen Wang, Shaonan Yan, Fan Yang, Longkui Xiang, et al. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. medRxiv preprint. doi:10.1101/2020.02.19.20025239.Google Scholar While it may relate to secondary infection especially at the end stage of disease. Fungal infection was rare than bacterial infection in this study, but it still needs to be concerned. The other two independent high-risk factors, increased blood urine nitrogen and lactate dehydrogenase were related to renal failure, heart failure or multi organ failure (MOF) which may lead to fatality of COVID-19. It was reported that cardiovascular complications were common in patients with SARS.4Yu C.M. Wong R.S. Sung J.J. et al. cardiovascular complications of severe acute respiratory syndrome.Postgrad Med J. 2006; 82: 140-144Crossref PubMed Scopus (267) Google Scholar Recent study demonstrated ACE-2 receptor of SARS-CoV was highly expressed in renal tubules.5Poissy J. Goffard A. Parmentier-Decrucq E. et al.Kinetics and pattern of viral excretion in biological specimens of two MERS-COV cases.J Clin Virol. 2014; 61: 275-278Crossref PubMed Scopus (70) Google Scholar The kidney injury may be caused by coronavirus which entering kidney cells through an ACE2-dependent pathway.6Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 Mar 20. pii: S0085-2538(20)30255-6. doi: 10.1016/j.kint.2020.03.005. [Epub ahead of print].Google Scholar Moreover, MOF is regarded as a predictive factor related to most end stage of diseases. As a gauge of inflammation, C-reactive protein showed a significant difference between death and recovery groups, so as d-Dimer. Nonetheless, those were excluded from final multivariate risk model. It needs more clinical data to interpret. The severity of our patients is more than that of Wenzhou may due to lack of medical resources during the outbreak. But another concern maybe virulence evolution.7Alizon S. Hurford A. Mideo N. Van Baalen M. Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future.J Evol Biol. 2009; 22: 245-259Crossref PubMed Scopus (593) Google Scholar In conclusion, during early period of COVID-19, old age (>70 years), increased neutrophil count and multi organ failure were high-risk factors related to outcome of critical patients. Early identification of critical type is more crucial.